Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fused tricyclic pyrazolo-dihydropyrazinyl-pyridone compounds as antivirals

Fused tricyclic pyrazolo-dihydropyrazinyl-pyridone compounds as antivirals

US Patent 11234977 · Granted Feb 1, 2022

Estimated economic value: $13,436,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Processes of making 3-fluoro-5-(((1S,2aR)-1,3,3,4,4-pentafluoro-2a-hydroxy-2,2a,2025
Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alp2025
Antiviral pyrazolopiridinone compounds2025
Antiviral 1,3-di-oxo-indene compounds2025
Fused tricyclic ring derivatives as SRC homology-2 phosphate inhibitors2025
2,3-dihydrobenzo[b]thiophene derivatives as hypoxia inducible factor-2(alpha) in2024
Antiviral 1,3-di-oxo-indene compounds2024
Indane derivatives as hypoxia inducible factor-2(α) inhibitors2024
Compounds and compositions for the treatment of cryptosporidiosis2024
Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alp2023
Compounds and compositions as protein kinase inhibitors2023
Antiviral pyrazolopyridinone compounds2023